Cargando…

Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial

There has been increased interest in hypofractionated accelerated chemoradiation for head and neck cancer during the recent first peak of the COVID-19 pandemic. Prospective data regarding this approach from randomised trials is lacking. In the PET NECK study, 564 patients with squamous cell carcinom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vreugdenhil, M., Fong, Charles, Sanghera, Paul, Hartley, Andrew, Dunn, Janet, Mehanna, Hisham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733600/ https://www.ncbi.nlm.nih.gov/pubmed/33321287 http://dx.doi.org/10.1016/j.oraloncology.2020.105112

Ejemplares similares

Assessing Novel Drugs and Radiation Technology in the Chemoradiation of Oropharyngeal Cancer
por: Cristaudo, Agostino, et al.
Publicado: (2018)

Revised Modelling of the Addition of Synchronous Chemotherapy to Radiotherapy in Squamous Cell Carcinoma of the Head and Neck—A Low α/β?
por: Best, James, et al.
Publicado: (2018)

Head and neck surgery recommendations during the COVID-19 pandemic – Author's reply
por: Mehanna, Hisham
Publicado: (2020)

FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer
por: Ulrich, Ethan J., et al.
Publicado: (2019)

Role of Repeat PET/CT Imaging in Head and Neck Cancer Following Initial Incomplete PET/CT Response to Chemoradiation
por: Iovoli, Austin J., et al.
Publicado: (2021)

Barriers to recruitment for surgical trials in head and neck oncology: a survey of trial investigators
por: Kaur, Geetinder, et al.
Publicado: (2013)

Feasibility of recruitment to an oral dysplasia trial in the United Kingdom
por: Nankivell, Paul, et al.
Publicado: (2012)

An Extended Hypofractionated Palliative Radiotherapy Regimen for Head and Neck Carcinomas
por: Laursen, Michael, et al.
Publicado: (2018)

Hypofractionated Radiotherapy for Palliation in Locally Advanced Head and Neck Cancer
por: Spartacus, RK, et al.
Publicado: (2017)

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells
por: Möckelmann, Nikolaus, et al.
Publicado: (2016)

Management of Chemoradiation-Induced Mucositis in Head and Neck Cancers With Oral Glutamine
por: Pattanayak, Lucy, et al.
Publicado: (2016)

Adapting Head and Neck Cancer Management in the Time of COVID-19
por: Mehanna, Hisham, et al.
Publicado: (2020)

Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy
por: Yamazaki, Hideya, et al.
Publicado: (2011)

Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects
por: Payne, Karl, et al.
Publicado: (2019)

Characterizing the epithelial–mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma
por: Payne, Karl, et al.
Publicado: (2022)

Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer
por: Sridharan, Vishwajith, et al.
Publicado: (2016)

Narrative review of the management of oral mucositis during chemoradiation for head and neck cancer
por: Judge, Lauren F., et al.
Publicado: (2021)

Intravenous fluids for pain management in head and neck cancer patients undergoing chemoradiation
por: Rivers, Charlotte I., et al.
Publicado: (2021)

Effect of vocal rehabilitation after chemoradiation for non-laryngeal head and neck cancers
por: Sreenivas, Athulya, et al.
Publicado: (2021)

The Effect of Radiation and Chemoradiation Therapy on the Head and Neck Mucosal Microbiome: A Review
por: Zagury-Orly, Ivry, et al.
Publicado: (2021)

Assessment of the Role of Gefitinib With Concurrent Chemoradiation in Locally Advanced Head and Neck Cancer
por: Prajapati, Raju, et al.
Publicado: (2022)

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
por: Rades, Dirk, et al.
Publicado: (2023)

Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma
por: Hollows, Robert, et al.
Publicado: (2018)

Randomized trial on acute toxicities of weekly vs three‐weekly cisplatin‐based chemoradiation in head and neck cancer
por: Ameri, Ahmad, et al.
Publicado: (2021)

Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma
por: Bryant, Jennifer, et al.
Publicado: (2019)

Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival
por: Iqbal, Muhammad Shahid, et al.
Publicado: (2016)

Voice and speech outcomes of chemoradiation for advanced head and neck cancer: a systematic review
por: Jacobi, Irene, et al.
Publicado: (2010)

Analysis of pharyngeal edema post‐chemoradiation for head and neck cancer: Impact on swallow function
por: Turcotte, Maria C., et al.
Publicado: (2018)

A review of weight loss and sarcopenia in patients with head and neck cancer treated with chemoradiation
por: Baxi, Shrujal S., et al.
Publicado: (2016)

Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients
por: Sridharan, Vishwajith, et al.
Publicado: (2016)

LIHNCS - Lugol’s iodine in head and neck cancer surgery: a multicentre, randomised controlled trial assessing the effectiveness of Lugol’s iodine to assist excision of moderate dysplasia, severe dysplasia and carcinoma in situ at mucosal resection margins of oral and oropharyngeal squamous cell carcinoma: study protocol for a randomised controlled trial
por: McCaul, James A, et al.
Publicado: (2013)

Hypofractionated Palliative Radiotherapy in Locally Advanced Inoperable Head and Neck Cancer: CMC Vellore Experience
por: Das, Saikat, et al.
Publicado: (2013)

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
por: Jacinto, Alexandre Arthur, et al.
Publicado: (2018)

Pretreatment subcutaneous adipose tissue predicts the outcomes of patients with head and neck cancer receiving definitive radiation and chemoradiation in Taiwan
por: Pai, Ping Ching, et al.
Publicado: (2018)

Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
por: Dejaco, Daniel, et al.
Publicado: (2020)

Metronomic adjuvant chemotherapy evaluation in locally advanced head and neck cancers post radical chemoradiation – a randomised trial
por: Patil, Vijay, et al.
Publicado: (2023)

A Unique Complication Associated with Concurrent Chemoradiation for the Treatment of Locally Advanced Head and Neck Cancer
por: Cahlon, Oren, et al.
Publicado: (2008)

Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer
por: Melotek, James M., et al.
Publicado: (2016)

The Lived Experiences of Patients with Head and Neck Cancer during Concurrent Chemoradiation Therapy Care Process
por: Kongwattanakul, Sirikorn, et al.
Publicado: (2020)

Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping
por: Payne, Karl, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ntmc4jj2ffl7uahpccfe8krmam